Are hip resurfacing arthroplasties meeting the needs of our patients? A 2-year follow-up study.
Hip resurfacing arthroplasty (HRA) is a treatment of end-stage hip arthritis in young patients with excellent bone stock. One hundred four consecutive HRAs (Depuy ASR, Warsaw, Ind) were performed with 36-Item Short Form Health Survey (SF-36), Western Ontario and McMaster University Osteoarthritis Index, Harris Hip Scores, and University of California, Los Angeles activity ratings obtained preoperatively, at 6 months, and at 1 and 2 years postoperatively. Four patients required conversion to total hip arthroplasty. All patients showed significant improvements in their activity, pain, stiffness, and function postoperatively. Patients with lower SF-36 mental component scores (MCSs) improved their MCS compared with those of the general population, as well as improving their pain and physical functioning scores. These findings demonstrate reliable improvements in standard quality of life measures in patients undergoing HRA, including those with low preoperative SF-36 MCS.